AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 1 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $512,157 | +904.2% | 34,258 | +344.6% | 0.00% | – |
Q2 2022 | $51,000 | -70.3% | 7,706 | -74.9% | 0.00% | – |
Q1 2022 | $172,000 | -40.3% | 30,694 | -50.1% | 0.00% | – |
Q4 2021 | $288,000 | +18.0% | 61,509 | +56.1% | 0.00% | – |
Q3 2021 | $244,000 | -24.7% | 39,406 | -19.9% | 0.00% | – |
Q2 2021 | $324,000 | -13.6% | 49,215 | -4.0% | 0.00% | -100.0% |
Q1 2021 | $375,000 | – | 51,251 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,952,958 | $22,809,000 | 0.60% |
SECTORAL ASSET MANAGEMENT INC | 1,151,175 | $6,642,000 | 0.47% |
X-Square Capital, LLC | 75,952 | $438,000 | 0.24% |
SABBY MANAGEMENT, LLC | 68,092 | $393,000 | 0.08% |
WealthTrust Axiom LLC | 22,347 | $128,000 | 0.05% |
Opaleye Management Inc. | 58,800 | $339,000 | 0.04% |
Trexquant Investment LP | 64,838 | $374,000 | 0.04% |
PDT Partners, LLC | 60,117 | $347,000 | 0.02% |
PERSONAL CFO SOLUTIONS, LLC | 13,000 | $75,000 | 0.02% |
CVI Holdings, LLC | 13,171 | $76,000 | 0.01% |